Thus, in patients after LSG and RYGB surgeries, there was a decrease in C-peptide levels, insulin, leptin, PAI, GIP, GLP-1, ghrelin, resistin, and visfatin compared with obese patients with T2DM before surgery (Figure 2). The gene discussed is NAMPT; the disease is type 2 diabetes mellitus.